Protection of nigral neurons by GDNF-engineered marrow cell transplantation

Kun Woo Park, Martin A. Eglitis, M. Maral Mouradian

Research output: Contribution to journalArticle

79 Citations (Scopus)

Abstract

Marrow stromal cells, which have many characteristics of stem cells, populate various non-hematopoietic tissues including the brain. In the present study, the cDNA for the dopaminergic neurotrophic factor Glial Cell Line-Derived Neurotrophic Factor (GDNF) was delivered using marrow cells in the mouse 1-Methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine (MPTP) model of Parkinson's disease. Following cross-sex intravenous bone marrow transplantation with male donor cells that had been transduced with GDNF (GDNF-BMT) or with non-manipulated marrow (Control-BMT), female recipient mice were subjected to systemic MPTP injections. Eight weeks after neurotoxin exposure, more tyrosine hydroxylase immunoreactive nigral neurons and striatal terminal density were observed in the GDNF-BMT mice compared with the Control-BMT group. In addition, following the expected initial behavioral hyperactivity in both groups, a significant difference in motor activity was detected between the two groups. GDNF immunoreactive male donor marrow derived cells were detected in the brains of GDNF-BMT mice but not in controls. These data indicate that marrow derived cells that seed the brain can express biologically active gene products and, therefore, can function as effective vehicles for therapeutic gene transfer to the brain.

Original languageEnglish
Pages (from-to)315-323
Number of pages9
JournalNeuroscience Research
Volume40
Issue number4
DOIs
Publication statusPublished - 2001 Jan 1
Externally publishedYes

Fingerprint

Glial Cell Line-Derived Neurotrophic Factor
Cell Transplantation
Substantia Nigra
Bone Marrow
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Brain
Corpus Striatum
Nerve Growth Factors
Neurotoxins
Tyrosine 3-Monooxygenase
Stromal Cells
Bone Marrow Transplantation
Genes
Parkinson Disease
Seeds
Motor Activity
Stem Cells
Complementary DNA
Neuroprotection
Neurons

Keywords

  • Bone marrow
  • GDNF
  • Gene therapy
  • MPTP
  • Parkinson
  • Transplantation
  • Tyrosine hydroxylase

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Protection of nigral neurons by GDNF-engineered marrow cell transplantation. / Park, Kun Woo; Eglitis, Martin A.; Mouradian, M. Maral.

In: Neuroscience Research, Vol. 40, No. 4, 01.01.2001, p. 315-323.

Research output: Contribution to journalArticle

Park, Kun Woo ; Eglitis, Martin A. ; Mouradian, M. Maral. / Protection of nigral neurons by GDNF-engineered marrow cell transplantation. In: Neuroscience Research. 2001 ; Vol. 40, No. 4. pp. 315-323.
@article{de7dc8475b10415aaed9440a3244ee3a,
title = "Protection of nigral neurons by GDNF-engineered marrow cell transplantation",
abstract = "Marrow stromal cells, which have many characteristics of stem cells, populate various non-hematopoietic tissues including the brain. In the present study, the cDNA for the dopaminergic neurotrophic factor Glial Cell Line-Derived Neurotrophic Factor (GDNF) was delivered using marrow cells in the mouse 1-Methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine (MPTP) model of Parkinson's disease. Following cross-sex intravenous bone marrow transplantation with male donor cells that had been transduced with GDNF (GDNF-BMT) or with non-manipulated marrow (Control-BMT), female recipient mice were subjected to systemic MPTP injections. Eight weeks after neurotoxin exposure, more tyrosine hydroxylase immunoreactive nigral neurons and striatal terminal density were observed in the GDNF-BMT mice compared with the Control-BMT group. In addition, following the expected initial behavioral hyperactivity in both groups, a significant difference in motor activity was detected between the two groups. GDNF immunoreactive male donor marrow derived cells were detected in the brains of GDNF-BMT mice but not in controls. These data indicate that marrow derived cells that seed the brain can express biologically active gene products and, therefore, can function as effective vehicles for therapeutic gene transfer to the brain.",
keywords = "Bone marrow, GDNF, Gene therapy, MPTP, Parkinson, Transplantation, Tyrosine hydroxylase",
author = "Park, {Kun Woo} and Eglitis, {Martin A.} and Mouradian, {M. Maral}",
year = "2001",
month = "1",
day = "1",
doi = "10.1016/S0168-0102(01)00242-5",
language = "English",
volume = "40",
pages = "315--323",
journal = "Neuroscience Research",
issn = "0168-0102",
publisher = "Elsevier Ireland Ltd",
number = "4",

}

TY - JOUR

T1 - Protection of nigral neurons by GDNF-engineered marrow cell transplantation

AU - Park, Kun Woo

AU - Eglitis, Martin A.

AU - Mouradian, M. Maral

PY - 2001/1/1

Y1 - 2001/1/1

N2 - Marrow stromal cells, which have many characteristics of stem cells, populate various non-hematopoietic tissues including the brain. In the present study, the cDNA for the dopaminergic neurotrophic factor Glial Cell Line-Derived Neurotrophic Factor (GDNF) was delivered using marrow cells in the mouse 1-Methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine (MPTP) model of Parkinson's disease. Following cross-sex intravenous bone marrow transplantation with male donor cells that had been transduced with GDNF (GDNF-BMT) or with non-manipulated marrow (Control-BMT), female recipient mice were subjected to systemic MPTP injections. Eight weeks after neurotoxin exposure, more tyrosine hydroxylase immunoreactive nigral neurons and striatal terminal density were observed in the GDNF-BMT mice compared with the Control-BMT group. In addition, following the expected initial behavioral hyperactivity in both groups, a significant difference in motor activity was detected between the two groups. GDNF immunoreactive male donor marrow derived cells were detected in the brains of GDNF-BMT mice but not in controls. These data indicate that marrow derived cells that seed the brain can express biologically active gene products and, therefore, can function as effective vehicles for therapeutic gene transfer to the brain.

AB - Marrow stromal cells, which have many characteristics of stem cells, populate various non-hematopoietic tissues including the brain. In the present study, the cDNA for the dopaminergic neurotrophic factor Glial Cell Line-Derived Neurotrophic Factor (GDNF) was delivered using marrow cells in the mouse 1-Methyl-4-phenyl-1,2,3,6-tetrahydro-pyridine (MPTP) model of Parkinson's disease. Following cross-sex intravenous bone marrow transplantation with male donor cells that had been transduced with GDNF (GDNF-BMT) or with non-manipulated marrow (Control-BMT), female recipient mice were subjected to systemic MPTP injections. Eight weeks after neurotoxin exposure, more tyrosine hydroxylase immunoreactive nigral neurons and striatal terminal density were observed in the GDNF-BMT mice compared with the Control-BMT group. In addition, following the expected initial behavioral hyperactivity in both groups, a significant difference in motor activity was detected between the two groups. GDNF immunoreactive male donor marrow derived cells were detected in the brains of GDNF-BMT mice but not in controls. These data indicate that marrow derived cells that seed the brain can express biologically active gene products and, therefore, can function as effective vehicles for therapeutic gene transfer to the brain.

KW - Bone marrow

KW - GDNF

KW - Gene therapy

KW - MPTP

KW - Parkinson

KW - Transplantation

KW - Tyrosine hydroxylase

UR - http://www.scopus.com/inward/record.url?scp=0034895752&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034895752&partnerID=8YFLogxK

U2 - 10.1016/S0168-0102(01)00242-5

DO - 10.1016/S0168-0102(01)00242-5

M3 - Article

VL - 40

SP - 315

EP - 323

JO - Neuroscience Research

JF - Neuroscience Research

SN - 0168-0102

IS - 4

ER -